Celanese Provides Non-US GAAP Financial Measure and Supplemental Information

Celanese Corporation (NYSE: CE) has recently released a document containing valuable information aimed at informing investors, analysts, and other interested parties regarding non-US GAAP financial measures and supplemental data. The document, last updated on November 4, 2024, aims to guide stakeholders in understanding the Company’s financial performance and operational results through the lens of these non-GAAP measures.

The purpose of the document includes providing insights into two key business segments of Celanese, namely Engineered Materials and the Acetyl Chain. The Company occasionally discloses non-GAAP financial measures to offer additional insights to stakeholders, believing them to be crucial in evaluating financial and operating results accurately.

Such non-GAAP financial measures are presented alongside reconciliations with the most directly comparable measures in accordance with US GAAP. Examples of these non-GAAP measures used by Celanese include adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, adjusted earnings per share, net debt, free cash flow, and return on invested capital (adjusted).

Adjusted EBIT is a key performance measure used by the Company, defined as net earnings attributable to Celanese Corporation after adjusting for certain items. Similarly, operating EBITDA and operating profit (loss) provide insight into operational performance, indicative of Celanese’s core operational strength.

Adjusted earnings per share is another significant metric, offering transparent information to stakeholders by adjusting earnings from continuing operations for specific items that affect comparability. Additionally, free cash flow, net debt, and return on invested capital (adjusted) serve as critical liquidity and operational metrics for assessing the Company’s financial health.

The document also delves into factors influencing segment net sales, cash dividends received, and return on invested capital calculations. For instance, factors affecting net sales sequentially and year-over-year are detailed for each business segment, providing valuable insights into volume, price, and currency impacts.

Celanese underscores that the presented results and adjustments have not been audited and should not be solely relied upon for future performance indications. The Company’s commitment to providing transparent financial information underscores its dedication to ensuring stakeholders have a comprehensive understanding of its financial health and operational performance.

The Company acknowledges the importance of presenting both GAAP and non-GAAP financial measures and reconciliations, offering a thorough view of its financial standing to support informed decision-making by investors, analysts, and other interested parties.

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Celanese’s 8K filing here.

About Celanese

Celanese Corporation, a chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. It operates through Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics.